BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27161077)

  • 1. Risk prediction of major complications in individuals with diabetes: the Atherosclerosis Risk in Communities Study.
    Parrinello CM; Matsushita K; Woodward M; Wagenknecht LE; Coresh J; Selvin E
    Diabetes Obes Metab; 2016 Sep; 18(9):899-906. PubMed ID: 27161077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
    Selvin E; Rawlings AM; Grams M; Klein R; Sharrett AR; Steffes M; Coresh J
    Lancet Diabetes Endocrinol; 2014 Apr; 2(4):279-288. PubMed ID: 24703046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
    Selvin E; Rawlings AM; Lutsey PL; Maruthur N; Pankow JS; Steffes M; Coresh J
    Circulation; 2015 Jul; 132(4):269-77. PubMed ID: 26022911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.
    Matsushita K; Sang Y; Ballew SH; Astor BC; Hoogeveen RC; Solomon SD; Ballantyne CM; Woodward M; Coresh J
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1770-7. PubMed ID: 24876355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
    Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
    Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.
    Ito R; Yamakage H; Kotani K; Wada H; Otani S; Yonezawa K; Ogo A; Okajima T; Adachi M; Araki R; Yoshida K; Saito M; Nagaoka T; Toyonaga T; Tanaka T; Yamada T; Ota I; Oishi M; Miyanaga F; Shimatsu A; Satoh-Asahara N;
    Endocr J; 2015; 62(2):201-7. PubMed ID: 25399862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    He J; Shlipak M; Anderson A; Roy JA; Feldman HI; Kallem RR; Kanthety R; Kusek JW; Ojo A; Rahman M; Ricardo AC; Soliman EZ; Wolf M; Zhang X; Raj D; Hamm L;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
    Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
    Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
    J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
    Hasslacher C; Kulozik F
    J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study.
    Gómez-Marcos MÁ; Recio-Rodríguez JI; Gómez-Sánchez L; Agudo-Conde C; Rodríguez-Sanchez E; Maderuelo-Fernandez J; Gomez-Sanchez M; García-Ortiz L;
    Cardiovasc Diabetol; 2015 Oct; 14():132. PubMed ID: 26427534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study.
    Alexander N; Matsushita K; Sang Y; Ballew S; Mahmoodi BK; Astor BC; Coresh J
    Am J Nephrol; 2015; 41(4-5):409-17. PubMed ID: 26139323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.
    Gori M; Gupta DK; Claggett B; Selvin E; Folsom AR; Matsushita K; Bello NA; Cheng S; Shah A; Skali H; Vardeny O; Ni H; Ballantyne CM; Astor BC; Klein BE; Aguilar D; Solomon SD
    Diabetes Care; 2016 May; 39(5):677-85. PubMed ID: 26740635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Incident Atrial Fibrillation in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study.
    Zelnick LR; Shlipak MG; Soliman EZ; Anderson A; Christenson R; Lash J; Deo R; Rao P; Afshinnia F; Chen J; He J; Seliger S; Townsend R; Cohen DL; Go A; Bansal N
    Clin J Am Soc Nephrol; 2021 Jul; 16(7):1015-1024. PubMed ID: 34597264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study.
    Beatty AL; Ku IA; Bibbins-Domingo K; Christenson RH; DeFilippi CR; Ganz P; Ix JH; Lloyd-Jones D; Omland T; Sabatine MS; Schiller NB; Shlipak MG; Skali H; Takeuchi M; Vittinghoff E; Whooley MA
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26150476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Disease Biomarkers Improve Heart Failure Risk Prediction in the General Population.
    Nowak C; Ärnlöv J
    Circ Heart Fail; 2020 Aug; 13(8):e006904. PubMed ID: 32757644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis.
    Avinash S; Singh VP; Agarwal AK; Chatterjee S; Araya V
    J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.